Effects of CYP2C9 and VKORC1 polymorphisms on warfarin sensitivity and responsiveness during the stabilization phase of therapy LN Al-Eitan, AY Almasri, RH Khasawneh Saudi Pharmaceutical Journal 27 (4), 484-490, 2019 | 46 | 2019 |
Impact of CYP2C9 and VKORC1 Polymorphisms on Warfarin Sensitivity and Responsiveness in Jordanian Cardiovascular Patients during the Initiation Therapy LN Al-Eitan, AY Almasri, RH Khasawneh Genes 9 (12), 578, 2018 | 41 | 2018 |
Influence of CYP4F2, ApoE, and CYP2A6 gene polymorphisms on the variability of Warfarin dosage requirements and susceptibility to cardiovascular disease in Jordan LN Al-Eitan, AY Almasri, AH Alnaamneh, HA Aman, NN Alrabadi, ... International journal of medical sciences 18 (3), 826, 2021 | 17 | 2021 |
Effects of coagulation factor VII polymorphisms on warfarin sensitivity and responsiveness in Jordanian cardiovascular patients during the initiation and maintenance phases of … LN Al-Eitan, AY Almasri, SO Al-Habahbeh Pharmacogenomics and personalized medicine, 1-8, 2019 | 17 | 2019 |
Influence of PSRC1, CELSR2, and SORT1 gene polymorphisms on the variability of warfarin dosage and susceptibility to cardiovascular disease LN Al-Eitan, BZ Elsaqa, AY Almasri, HA Aman, RH Khasawneh, ... Pharmacogenomics and Personalized Medicine, 619-632, 2020 | 16 | 2020 |
Impact of a variable number tandem repeat in the CYP2C9 promoter on warfarin sensitivity and responsiveness in Jordanians with cardiovascular disease LN Al-Eitan, AY Almasri, SO Al-Habahbeh Pharmacogenomics and personalized medicine, 15-22, 2019 | 15 | 2019 |
The impact of potassium channel gene polymorphisms on antiepileptic drug responsiveness in Arab patients with epilepsy LN Al-Eitan, IM Al-Dalalah, AK Elshammari, WH Khreisat, AY Almasri Journal of Personalized Medicine 8 (4), 37, 2018 | 15 | 2018 |
Variants in CDHR3, CACNAC1, and LTA Genes Predisposing Sensitivity and Response to Warfarin in Patients with Cardiovascular Disease MA Alghamdi, L Al-Eitan, R Alkhatib, A Al-Assi, A Almasri, H Aljamal, ... International Journal of General Medicine, 1093-1100, 2021 | 7 | 2021 |
Impact of PCSK9, WDR12, CDKN2A, and CXCL12 polymorphisms in Jordanian cardiovascular patients on warfarin responsiveness and sensitivity RK Ibdah, LN Al-Eitan, NN Alrabadi, AY Almasri, AH Alnaamneh, ... International Journal of General Medicine, 103-118, 2021 | 7 | 2021 |
Influence of SH2B3, MTHFD1L, GGCX, and ITGB3 Gene Polymorphisms on theVariability on Warfarin Dosage Requirements and Susceptibility to CVD in the … LN Al-Eitan, AY Almasri, RH Khasawneh, MA Alghamdi Journal of Personalized Medicine 10 (3), 117, 2020 | 5 | 2020 |
Effect of MEF2A and SLC22A3-LPAL2-LPA gene polymorphisms on warfarin sensitivity and responsiveness in Jordanian cardiovascular patients LN Al-Eitan, AY Almasri, AH Alnaamneh, A Mihyar Plos one 18 (11), e0294226, 2023 | 2 | 2023 |